Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1897 1
1908 1
1913 1
1919 1
1929 1
1935 1
1945 1
1946 6
1947 9
1948 5
1949 6
1950 2
1951 3
1952 3
1953 2
1954 1
1956 1
1957 1
1958 5
1959 4
1960 3
1961 3
1962 6
1963 3
1964 3
1965 3
1966 2
1967 3
1968 8
1969 10
1970 12
1971 10
1972 17
1973 15
1974 21
1975 33
1976 26
1977 37
1978 36
1979 34
1980 32
1981 25
1982 39
1983 32
1984 44
1985 38
1986 65
1987 81
1988 60
1989 77
1990 63
1991 96
1992 98
1993 93
1994 142
1995 142
1996 150
1997 146
1998 193
1999 182
2000 185
2001 210
2002 231
2003 296
2004 339
2005 334
2006 369
2007 404
2008 451
2009 466
2010 557
2011 612
2012 687
2013 729
2014 747
2015 819
2016 888
2017 960
2018 1060
2019 1119
2020 1376
2021 1526
2022 1443
2023 1044
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17,028 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.
Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA; IMpower150 Study Group. Reck M, et al. Among authors: lee a. Lancet Respir Med. 2019 May;7(5):387-401. doi: 10.1016/S2213-2600(19)30084-0. Epub 2019 Mar 25. Lancet Respir Med. 2019. PMID: 30922878 Clinical Trial.
Glioblastoma remodelling of human neural circuits decreases survival.
Krishna S, Choudhury A, Keough MB, Seo K, Ni L, Kakaizada S, Lee A, Aabedi A, Popova G, Lipkin B, Cao C, Nava Gonzales C, Sudharshan R, Egladyous A, Almeida N, Zhang Y, Molinaro AM, Venkatesh HS, Daniel AGS, Shamardani K, Hyer J, Chang EF, Findlay A, Phillips JJ, Nagarajan S, Raleigh DR, Brang D, Monje M, Hervey-Jumper SL. Krishna S, et al. Among authors: lee a. Nature. 2023 May;617(7961):599-607. doi: 10.1038/s41586-023-06036-1. Epub 2023 May 3. Nature. 2023. PMID: 37138086 Free PMC article.
Circular RNA vaccine induces potent T cell responses.
Amaya L, Grigoryan L, Li Z, Lee A, Wender PA, Pulendran B, Chang HY. Amaya L, et al. Among authors: lee a. Proc Natl Acad Sci U S A. 2023 May 16;120(20):e2302191120. doi: 10.1073/pnas.2302191120. Epub 2023 May 8. Proc Natl Acad Sci U S A. 2023. PMID: 37155869 Free PMC article.
Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.
Shishehbor MH, Powell RJ, Montero-Baker MF, Dua A, Martínez-Trabal JL, Bunte MC, Lee AC, Mugglin AS, Mills JL, Farber A, Clair DG; PROMISE II Investigators. Shishehbor MH, et al. Among authors: lee ac. N Engl J Med. 2023 Mar 30;388(13):1171-1180. doi: 10.1056/NEJMoa2212754. N Engl J Med. 2023. PMID: 36988592
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators. Carrier M, et al. Among authors: lee ayy. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. N Engl J Med. 2019. PMID: 30511879 Clinical Trial.
Fezolinetant: First Approval.
Lee A. Lee A. Drugs. 2023 Aug;83(12):1137-1141. doi: 10.1007/s40265-023-01917-1. Drugs. 2023. PMID: 37462862 Review.
Omaveloxolone: First Approval.
Lee A. Lee A. Drugs. 2023 Jun;83(8):725-729. doi: 10.1007/s40265-023-01874-9. Drugs. 2023. PMID: 37155124 Review.
Effect of Shared Decision-Making for Stroke Prevention on Treatment Adherence and Safety Outcomes in Patients With Atrial Fibrillation: A Randomized Clinical Trial.
Noseworthy PA, Branda ME, Kunneman M, Hargraves IG, Sivly AL, Brito JP, Burnett B, Zeballos-Palacios C, Linzer M, Suzuki T, Lee AT, Gorr H, Jackson EA, Hess E, Brand-McCarthy SR, Shah ND, Montori VM; SDM4AFib (Shared Decision‐Making for Atrial Fibrillation) Trial Investigators *. Noseworthy PA, et al. Among authors: lee at. J Am Heart Assoc. 2022 Jan 18;11(2):e023048. doi: 10.1161/JAHA.121.023048. Epub 2022 Jan 13. J Am Heart Assoc. 2022. PMID: 35023356 Free PMC article. Clinical Trial.
17,028 results
You have reached the last available page of results. Please see the User Guide for more information.